Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.

Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, Myung SJ, Kim YJ, Lee HS.

Cancer Lett. 2010 Dec 1;298(1):9-15. doi: 10.1016/j.canlet.2010.05.020. Epub 2010 Jun 22.

PMID:
20573444
2.

Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.

Lee JH, Yoon JH, Yu SJ, Chung GE, Jung EU, Kim HY, Kim BH, Choi DH, Myung SJ, Kim YJ, Kim CY, Lee HS.

Cancer Lett. 2010 Sep 28;295(2):229-35. doi: 10.1016/j.canlet.2010.03.005. Epub 2010 Mar 28.

PMID:
20350780
3.

Enhanced interleukin-2 diphtheria toxin conjugate-induced growth suppression in retinoic acid-treated hypoxic hepatocellular carcinoma cells.

Kim BH, Yoon JH, Myung SJ, Lee JH, Lee SH, Lee SM, Lee HS.

Cancer Lett. 2009 Feb 18;274(2):259-65. doi: 10.1016/j.canlet.2008.09.025. Epub 2008 Nov 4.

PMID:
18986761
4.

Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma.

Sibold S, Roh V, Keogh A, Studer P, Tiffon C, Angst E, Vorburger SA, Weimann R, Candinas D, Stroka D.

FEBS Lett. 2007 Mar 6;581(5):989-94. Epub 2007 Feb 7.

5.

N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.

Akiba J, Ogasawara S, Kawahara A, Nishida N, Sanada S, Moriya F, Kuwano M, Nakashima O, Yano H.

Oncol Rep. 2008 Dec;20(6):1329-35.

PMID:
19020710
6.

Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.

Kwak MS, Yu SJ, Yoon JH, Lee SH, Lee SM, Lee JH, Kim YJ, Lee HS, Kim CY.

J Cancer Res Clin Oncol. 2015 Nov;141(11):2037-45. doi: 10.1007/s00432-015-1990-6. Epub 2015 May 20.

PMID:
25989942
7.

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L.

Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24.

PMID:
21763068
8.

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.

Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR.

BMC Cancer. 2006 Oct 2;6:232.

9.

Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.

Tak E, Lee S, Lee J, Rashid MA, Kim YW, Park JH, Park WS, Shokat KM, Ha J, Kim SS.

J Hepatol. 2011 Feb;54(2):328-39. doi: 10.1016/j.jhep.2010.06.045. Epub 2010 Sep 17.

PMID:
21056497
10.

Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.

Said HM, Stein S, Hagemann C, Polat B, Staab A, Anacker J, Schoemig B, Theobald M, Flentje M, Vordermark D.

Oncol Rep. 2009 Jan;21(1):237-46.

PMID:
19082468
11.

Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.

Miao J, Chen GG, Chun SY, Chak EC, Lai PB.

Int J Oncol. 2004 Sep;25(3):651-9.

PMID:
15289866
12.

N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.

Akiba J, Murakami Y, Noda M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H.

Cancer Lett. 2011 Nov 1;310(1):25-34. doi: 10.1016/j.canlet.2011.05.034. Epub 2011 Jun 24.

PMID:
21775055
13.

N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells.

Yan X, Chua MS, Sun H, So S.

Cancer Lett. 2008 Apr 8;262(1):133-42. doi: 10.1016/j.canlet.2007.12.010. Epub 2008 Jan 22.

PMID:
18207320
14.

Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.

Zheng T, Wang J, Song X, Meng X, Pan S, Jiang H, Liu L.

J Cancer Res Clin Oncol. 2010 Oct;136(10):1597-604. doi: 10.1007/s00432-010-0817-8. Epub 2010 Feb 20.

PMID:
20174822
15.

Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma.

Al-Rawashdeh FY, Scriven P, Cameron IC, Vergani PV, Wyld L.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1099-105. doi: 10.1097/MEG.0b013e3283378405.

PMID:
20177386
16.

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.

Cancer Res. 2010 Jun 15;70(12):5184-93. doi: 10.1158/0008-5472.CAN-10-0145. Epub 2010 May 25.

17.

STAT3 & Cytochrome P450 2C9: a novel signaling pathway in liver cancer stem cells.

Myung SJ, Yoon JH, Yu SJ.

Biomed Pharmacother. 2012 Dec;66(8):612-6. doi: 10.1016/j.biopha.2012.08.011. Epub 2012 Sep 25.

PMID:
23089473
18.

An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.

Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT, Fan ST.

Clin Cancer Res. 2009 May 15;15(10):3462-71. doi: 10.1158/1078-0432.CCR-08-2127. Epub 2009 May 15.

19.

Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.

Said HM, Polat B, Staab A, Hagemann C, Stein S, Flentje M, Theobald M, Katzer A, Vordermark D.

Oncol Rep. 2008 Aug;20(2):413-9.

PMID:
18636206
20.

Expression and biological significance of c-FLIP in human hepatocellular carcinomas.

Du X, Bao G, He X, Zhao H, Yu F, Qiao Q, Lu J, Ma Q.

J Exp Clin Cancer Res. 2009 Feb 20;28:24. doi: 10.1186/1756-9966-28-24.

Items per page

Supplemental Content

Write to the Help Desk